Premium

Deep Dives

Extended analysis of longevity's most important topics. 800–1,200 words of evidence, context, and action.

Deep Dives are included in Premium and Ultimate subscriptions.

Subscribe from $10.99/month →
Issue #3·1100 words
Premium

The actual evidence on NMN

What 23 studies tell us about nicotinamide mononucleotide supplementation and whether it actually works.

Unlock this deep dive →
Issue #4·950 words
Premium

Why the TAME metformin trial matters

The Targeting Aging with Metformin trial could be the most important longevity study ever run.

Unlock this deep dive →
Issue #5·1050 words
Premium

Rapamycin in humans

The evidence, the risks, and the doctors actually prescribing it off-label.

Unlock this deep dive →
Issue #6·920 words
Premium

Zone 2 cardio vs. HIIT

What does the data actually show about different training modalities for longevity?

Unlock this deep dive →
Issue #7·880 words
Premium

Biological age clocks

How they work and whether they're clinically useful for tracking aging.

Unlock this deep dive →
Issue #8·1020 words
Premium

Cellular senescence

The zombie cell hypothesis, senolytic drugs, and what the evidence shows.

Unlock this deep dive →
Issue #9·950 words
Premium

The hallmarks update

What the 2023 revision changed and why it matters for longevity research.

Unlock this deep dive →
Issue #10·890 words
Premium

Caloric restriction in humans

The CALERIE trial and what it found about eating less and living longer.

Unlock this deep dive →
Issue #11·980 words
Premium

mTOR inhibition

From rapamycin to rapalogs — what's real vs. hype in the longevity space.

Unlock this deep dive →
Issue #12·1150 words
Premium

Epigenetic reprogramming

Yamanaka factors, partial reprogramming, and the risk of cancer.

Unlock this deep dive →